{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Biological+Control&page=23", "query": { "intervention": "Biological Control", "page": 23 }, "page_size": 10 }, "pagination": { "page": 23, "page_size": 10, "total_count": 1573, "total_pages": 158, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Biological+Control&page=24&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Biological+Control&page=22&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T05:52:59.700Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01225341", "title": "Botulinum Toxin A for Herpes Labialis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Herpes Labialis" ], "interventions": [ { "name": "onabotulinumtoxinA", "type": "DRUG" }, { "name": "Bacteriostatic normal saline", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "DeNova Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 20, "start_date": "2010-08", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2020-12-21", "last_synced_at": "2026-10-24T05:52:59.700Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01225341" }, { "nct_id": "NCT01245673", "title": "Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myeloma" ], "interventions": [ { "name": "Prevnar- Pneumococcal Conjugate Vaccine (PCV)", "type": "BIOLOGICAL" }, { "name": "Activated/costimulated autologous T-cell", "type": "OTHER" }, { "name": "Revlamid® (Lenalidomide)", "type": "DRUG" }, { "name": "MAGE-A3/GM-GSF, Hiltonol® (Poly-ICLC)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "OTHER", "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 28, "start_date": "2011-05-10", "completion_date": "2018-12", "has_results": true, "last_update_posted_date": "2020-04-06", "last_synced_at": "2026-10-24T05:52:59.700Z", "location_count": 2, "location_summary": "Baltimore, Maryland • Philadelphia, Pennsylvania", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01245673" }, { "nct_id": "NCT01211782", "title": "AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "caprylic triglyceride", "type": "DRUG" }, { "name": "long-chain triglyceride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cerecin", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "55 Years to 85 Years" }, "enrollment_count": 0, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2012-12-04", "last_synced_at": "2026-10-24T05:52:59.700Z", "location_count": 1, "location_summary": "St. Petersburg, Florida", "locations": [ { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01211782" }, { "nct_id": "NCT03799627", "title": "Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anemia", "Dialysis-dependent Chronic Kidney Disease" ], "interventions": [ { "name": "Vadadustat", "type": "DRUG" }, { "name": "Epoetin Alfa", "type": "DRUG" }, { "name": "Vadadustat TIW", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Akebia Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 175, "start_date": "2019-01-31", "completion_date": "2020-07-15", "has_results": true, "last_update_posted_date": "2022-09-29", "last_synced_at": "2026-10-24T05:52:59.700Z", "location_count": 41, "location_summary": "Fresno, California • Granada Hills, California • Los Angeles, California + 32 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03799627" }, { "nct_id": "NCT05772897", "title": "Parenting Skills Group for Mothers With Postpartum Depression", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Postpartum Depression" ], "interventions": [ { "name": "Circle of Security Parenting program", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 750, "start_date": "2023-08-03", "completion_date": "2035-06-01", "has_results": false, "last_update_posted_date": "2023-11-30", "last_synced_at": "2026-10-24T05:52:59.700Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05772897" }, { "nct_id": "NCT00923910", "title": "Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Leukemia, Acute Myelogenous (AML)", "Leukemia, Acute Lymphocytic (ALL)", "Leukemia, Chronic Myelogenous (CML)", "Myelodysplastic Syndrome (MDS)", "Non-Hodgkin's Lymphoma (NHL)" ], "interventions": [ { "name": "WT1 Peptide-Pulsed Dendritic Cells", "type": "DRUG" }, { "name": "Donor Lymphocytes", "type": "DRUG" }, { "name": "IL-4", "type": "DRUG" }, { "name": "KLH", "type": "DRUG" }, { "name": "WT1 Peptides", "type": "DRUG" }, { "name": "Endotoxin", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "74 Years", "sex": "ALL", "summary": "1 Year to 74 Years" }, "enrollment_count": 10, "start_date": "2008-02-22", "completion_date": "2016-11-15", "has_results": true, "last_update_posted_date": "2017-04-12", "last_synced_at": "2026-10-24T05:52:59.700Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00923910" }, { "nct_id": "NCT05441579", "title": "Recruitment and Behavioral Economic Strategies", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Surgery", "Adolescent Behavior" ], "interventions": [ { "name": "Behavioral Economics (BE) recruitment strategies", "type": "BEHAVIORAL" }, { "name": "Biofeedback-based virtual reality (VR-BF)", "type": "OTHER" }, { "name": "Manage My Pain", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Vanessa Olbrecht", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "12 Years to 18 Years" }, "enrollment_count": 128, "start_date": "2022-05-17", "completion_date": "2022-09-08", "has_results": true, "last_update_posted_date": "2024-12-20", "last_synced_at": "2026-10-24T05:52:59.700Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05441579" }, { "nct_id": "NCT03038243", "title": "Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in Adults", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Shigella Sonnei Dysenteries" ], "interventions": [ { "name": "Shigella flexneri 2a whole cell (Sf2aWC) vaccine and double mutant E. coli heat labile toxin (dmLT)", "type": "BIOLOGICAL" }, { "name": "Shigella flexneri 2a whole cell (Sf2aWC) vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "PATH", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 0, "start_date": "2017-08-01", "completion_date": "2019-12-31", "has_results": false, "last_update_posted_date": "2017-11-20", "last_synced_at": "2026-10-24T05:52:59.700Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03038243" }, { "nct_id": "NCT00518115", "title": "Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Albiglutide (GSK716155) or exenatide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 361, "start_date": "2007-04", "completion_date": "2008-05", "has_results": true, "last_update_posted_date": "2016-12-16", "last_synced_at": "2026-10-24T05:52:59.700Z", "location_count": 158, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Mobile, Alabama + 142 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Bull Shoals", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00518115" }, { "nct_id": "NCT04117074", "title": "Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Surgery", "Analgesia" ], "interventions": [ { "name": "Liposomal bupivacaine", "type": "DRUG" }, { "name": "Thoracic epidural analgesia (bupivacaine)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 106, "start_date": "2021-04-14", "completion_date": "2025-03-17", "has_results": true, "last_update_posted_date": "2026-05-19", "last_synced_at": "2026-10-24T05:52:59.700Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04117074" } ] }